MDA
GSK icon

Minot DeBlois Advisors’s GSK GSK Stock Holding History

Minot DeBlois Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.5K Hold
600
– – 0.03% 120
2026
Q1 		$33.1K Buy
600
+520
+650% +$28.2K 0.03% 118
2025
Q4 		$3.92K Sell
80
-520
-87% -$24.3K ﹤0.01% 170
2025
Q3 		$25.9K Hold
600
– – 0.02% 126
2025
Q2 		$23K Hold
600
– – 0.02% 131
2025
Q1 		$23.2K Hold
600
– – 0.02% 134
2024
Q4 		$20.3K Buy
+600
New +$21.6K 0.02% 170

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Minot DeBlois Advisors's GSK Position: Q2 2026 in Review

Minot DeBlois Advisors held its GSK (GSK) position steady in Q2 2026 at 600 shares worth $31.5K. The position accounts for 0.03% of the portfolio, ranked #120.

Minot DeBlois Advisors first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $33.1K in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Minot DeBlois Advisors held 600 shares of GSK worth $31.5K as of Q2 2026.
  • Minot DeBlois Advisors left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.03% of Minot DeBlois Advisors's portfolio in Q2 2026, its #120 holding.
  • Minot DeBlois Advisors first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
  • Minot DeBlois Advisors's GSK position peaked at $33.1K in Q1 2026.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Minot DeBlois Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.